Our company is a second-generation startup model company established as a joint venture between a research institute, a company and a researcher by investing in kind the original technology of the Korea Institute of Science and Technology (KIST). We specialize in R&D of high-tech products that extend life and improve quality of life for chronic diseases such as skin and ophthalmic diseases and cancer by applying drug/excipient nano-repositioning platform technology. We are currently preparing for an IPO based on clinical trials and research results. 2022 01.ISO 13485 accreditation 02.Selected customized support program related to global business establishment by KOTRA. 03.Certified of Medical device Manufacturing for RHINOdeLIGHT 2021 07.Certified of medical device Manufacturing for RHINOdeLIGHT/RHINOdeLIGHT Combo(for export) 12.Head office relocation (Songpa -> Seongbuk) Company affiliated research center relocation (Sonpa -> Jungnang) 2020 01.Head office relocation (Seongbuk -> Songpa) 03.Certified as a small and medium Business 03.Certified of Good Manufacture Practices (GMP) 04.Certified of Medical device Manufacturing for DERMAdeLIGHT 09.Certified as a LMO 2019 01.Registered as a new technology start-up company 01.Reselected as a start-up business support program by Seoul Business Growth Center 02.Certified as a venture company 04.Medical device clinical trial approval 05.Started medical device clinical trial 2018 02.Selected as a start-up business support program by Seoul Business Growth Center 04.Head office relocation (Yongsan -> Seongbuk) 05.Selected as an investment-linked R&D program by commercializations Promotion Agency for R&D Outcomes 06.Company affiliated research center certified 08.Certified of Good Manufacture Practices (Clinical trial GMP) 2017 11.Good Manufacturing Practices (GMP) Production process development 2016 11.Acne treatment development research 2015 12.Established D.R.NANO Co., Ltd